Nicola Maurea

29PUBLICATIONS
85CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)BacteriologyCardiology (incl. cardiovascular diseases)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jun 26, 2026
Cardiovascular Toxicity of Novel HER2-Targeted Agents and Multikinase Inhibitors in Oncology: From Mechanisms to Real-World Clinical Evidence.

|Jun 12, 2026
Heart-Type Fatty Acid-Binding Protein (H-FABP) as a Candidate Adjunctive Biomarker for Immune Checkpoint Inhibitor-Related Cardiotoxicity: Linking Early Immune-Metabolic Myocardial Injury with Translational Cardio-Oncology.

|May 04, 2026
SGLT2 Inhibitor Dapagliflozin Attenuates Cardiomyocyte Injury and Inflammation Induced by PI3Kα-Selective Inhibitor Alpelisib and Fulvestrant Under Hyperglycemia.

|Mar 14, 2026
A Silent Saboteur of Immunotherapy: Antibiotic Use and Its Impact on Immune Checkpoint Inhibitors Efficacy, a Systematic Review and Meta-Analysis of Recent Studies.

Giuliana Ciappina, Enrica Toscano, Giordana Di Mauro

|Oct 29, 2025
Fusobacteriumnucleatum: Pathophysiological and Clinical Involvement in Inflammatory Bowel Diseases, Colorectal Cancer and Cardiovascular Diseases.

Vincenzo Quagliariello, Pietro Forte, Giuliana Ciappina

|Oct 29, 2025
Healthcare Management in Cardio-Oncology, Clinical Strategies and Future Perspectives: A Narrative Review.

Vincenzo Quagliariello, Massimiliano Berretta, Fabrizio Maurea

Pageof 5

Frequent Collaborators

18 joint publications

Massimiliano Berretta

17 joint publications

Vincenzo Quagliariello

8 joint publications

Domenico Gabrielli

7 joint publications

Alessandro Ottaiano